61Indexed trials
canonical disease area
Neuro-Oncology
Intelligence
Neuro-Oncology intelligence: 61 indexed trials, 18 recruiting studies, 54 sponsors across 38 countries.
18Recruiting
54Sponsors
38Countries
Leading sponsors
Annick Desjardins20 recruiting
National Cancer Institute (NCI)20 recruiting
NeuroVita Clinic20 recruiting
University of Texas Southwestern Medical Center20 recruiting
Assistance Publique - Hôpitaux de Paris21 recruiting
Cortice Biosciences, Inc.20 recruiting
Hoffmann-La Roche21 recruiting
Beijing Neurosurgical Institute10 recruiting
DelMar Pharmaceuticals, Inc.10 recruiting
Assiut University10 recruiting
Costas Hadjipanayis11 recruiting
Constantinos Hadjipanayis10 recruiting
Geographic activity
United States33trials
Germany13trials
Netherlands9trials
France9trials
Austria6trials
Switzerland6trials
Canada5trials
Spain5trials
Belgium5trials
Denmark4trials
Israel4trials
Italy4trials
Leading interventions
Bevacizumab5trials
Temozolomide4trials
Dendritic vaccine, allogeneic hematopoietic stem cells, cytotoxic lymphocytes2trials
Radiation therapy2trials
TPI 2872trials
Dendritic vaccine, autologous hematopoietic stem cells, cytotoxic lymphocytes2trials
radiotherapy2trials
APG1011trials
ACT0011trials
5-ALA1trials
Alectinib1trials
Adjuvant chemotherapy as normal based on standard clinical protocols determined by the neuro-oncologist1trials
Methodology note
This entity is derived from structured ClinicalTrials.gov conditions and/or MeSH normalization. Counts reflect the current NeuroRisk indexed corpus and are not guaranteed exhaustive global totals.